Compare the Renal Protective Effects of Febuxostat and Benzbromarone

NACompletedINTERVENTIONAL

Enrollment

160

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions

Chronic Kidney DiseaseHyperuricemiaAbnormal Renal Function

Interventions

DRUG

Febuxostat

It acts as an inhibitor of xanthine oxidase, thus lowering urate concentrations in the body

DRUG

Benzbromarone

It is structurally related to the antiarrhythmic amiodarone, and it is a uricosuric agent and non-competitive inhibitor of xanthine oxidase

Trial Locations (1)

Department of Nephrology & Rheumatology, Shanghai Tenth People's Hospital, Shanghai

All Listed Sponsors

lead

Shanghai 10th People's Hospital

OTHER

NCT02338323 - Compare the Renal Protective Effects of Febuxostat and Benzbromarone | Biotech Hunter | Biotech Hunter